GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...

Research presented at the American Diabetes Association (ADA) annual meeting included a small phase I/II study on stem cell ...

Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...

Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

Classically, the diagnosis of type 1 diabetes comes after a patient presents with unexplained weight loss, extreme thirst and frequent urination and a lab test reveals off-the-charts blood glucose ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...